American Health (002044.SZ) announced its first-half results, with a net loss of 182 million yuan to the mother

According to the Zhitong Finance App, American Health (002044.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 3.844 billion yuan, a year-on-year decrease of 6.45%. The net loss attributable to shareholders of the listed company was 182 million yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring profit and loss was 207 million yuan.

Among the main revenue, revenue obtained by combining AI technology was 218.941 million yuan, an increase of 55.96% over the same period last year. It mainly includes revenue from projects such as cardiopulmonary screening, AI bone density, capsule gastroscopy, AI-MDT reports, pulmonary stenosis, and brain intelligence. The total number of visitors was 9.25 million, of which 5.75 million were received by the Holding Branch. The unit price for the company's medical examiner in the first half of 2026 was 628 yuan. During the reporting period, the main reasons for the change in performance: 1) The industry in which the company is located has strong seasonal characteristics. In the first half of the year, due to the traditional off-season, due to the distribution of holidays and the financial accounting cycle of enterprises and institutions, some corporate budgets were put back behind; 2) The company's overall order signing was relatively stable, and the business affected by the pace of inspection will be gradually released in the second half of the year. The company will actively promote the business growth of high-quality customers in the government, enterprise, banking, insurance and other industries, continue to increase the proportion of national customers signing orders and inspection shares; 3) In the first half of the year, efficiency improvements and cost reductions continued to advance steadily based on AI Digitalization is actively promoted Improve efficiency and reduce costs and innovate income-generating efforts to better meet the peak medical examination season in the second half of the year.